Companion Diagnostic Tools

In addition to its R&D program on novel cancer therapeutic agents, Theramir is developing companion diagnostics tools to facilitate discovery of novel microRNA-based biomarkers of tumor progression, to identify valid oncoprotein targets in different cancer types and to enable the early detection of cancer disease. The company’s efforts in this area are focused on providing the tools and resources to enable the optimum selection of patients who can potentially benefit from its therapeutic approaches and as well as on developing further opportunities for diagnostic and pharmacological intervention in a range of malignant cancers